Awesome!

---

A new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiveness against human cancer cells grown in the laboratory and in mice, according to a study by researchers at the Stanford University School of Medicine.

The ability to circumvent the exhaustion that the genetically engineered cells often experience after their initial burst of activity could lead to the development of a new generation of CAR-T cells that may be effective even against solid cancers—a goal that has until now eluded researchers.

The studies were conducted in mice harboring human leukemia and bone cancer cells. The researchers hope to begin clinical trials in people with leukemia within the next 18 months and to eventually extend the trials to include solid cancers.

A new University of Barcelona study reveals the first empirical genetic evidence of human self-domestication, a hypothesis that humans have evolved to be friendlier and more cooperative by selecting their companions depending on their behaviour. Researchers identified a genetic network involved in the unique evolutionary trajectory of the modern human face and prosociality, which is absent in the Neanderthal genome. The experiment is based on Williams Syndrome cells, a rare disease.

The study, published in Science Advances, results from the collaboration between a UB team led by Cedric Boeckx, ICREA professor from the Section of General Linguistics at the Department of Catalan Philology and General Linguistics, and member of the Institute of Complex Systems of the UB (UBICS), and researchers from the team led by Giuseppe Testa, lecturer at the University of Milan and the European Institute of Oncology.

Molecular biologist Fiona Behan reports on how the CRISPR gene-editing technique can find cancer’s weak points, identifying targets for new drugs.

Editing of hemoglobin gene leads two people with different conditions to no longer need regular blood transfusions.

Anzalone’s prime editor is a little different. Its enzyme is actually two that have been fused together—a molecule that acts like a scalpel combined with something called a reverse transcriptase, which converts RNA into DNA. His RNA guide is a little different too: It not only finds the DNA in need of fixing, but also carries a copy of the edit to be made. When it locates its target DNA, it makes a little nick, and the reverse transcriptase starts adding the corrected sequence of DNA letter by letter, like the strikers on a typewriter.

---

A less error-prone DNA editing method could correct many more harmful mutations than was previously possible.

It is the dream of every molecular geneticist: an easy-to-use program that compares datasets from different cellular conditions, identifies enhancer regions and then assigns them to their target genes. A research team led by Martin Vingron at the Max Planck Institute for Molecular Genetics in Berlin has now developed a program that does all of this.

“DNA is pretty boring, since it is practically the same in every cell,” says Martin Vingron, director and head of the Department of Bioinformatics at the Max Planck Institute for Molecular Genetics in Berlin. “While the genome is like the book of life, I am most interested in the side notes.”

These “notes” are small chemical marks attached to the DNA molecule that do not alter the genetic information itself, but influence what happens to the DNA at the respective site. In other words, these marks have an epigenetic effect. They serve as regulators of genomic regions that are responsible for the activation and deactivation of genes, such as promoters and enhancers.